Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)

被引：63
作者：
Leonard, JP
Link, BK
机构：
[1] Cornell Univ, Weill Med Coll, Ctr Lymphoma & Myeloma, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Div Hematol Oncol, New York, NY 10021 USA
[3] New York Presbyterian Hosp, New York, NY USA
[4] Univ Iowa, Coll Med, Holden Comprehens Canc Ctr, Iowa City, IA USA
[5] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期
关键词：
D O I：
10.1053/sonc.2002.30149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：81 / 86
页数：6
相关论文
共 50 条
[1]  
BAUM RP, 1994, CANCER, V73, P896, DOI 10.1002/1097-0142(19940201)73:3+<896::AID-CNCR2820731322>3.0.CO
[2]  
2-H
[3]  
Coiffier B, 2000, BLOOD, V96, p223A
[4]   HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor [J].
Elasser, D ;
Valerius, T ;
Repp, R ;
Weiner, GJ ;
Deo, Y ;
Kalden, JR ;
vandeWinkel, JGJ ;
Stevenson, GT ;
Glennie, MJ ;
Gramatzki, M .
BLOOD, 1996, 87 (09) :3803-3812
[5]  
ENGEL P, 1993, J IMMUNOL, V150, P4719
[6]  
EPSTEIN AL, 1987, CANCER RES, V47, P830
[7]  
GINGRICH RD, 1990, BLOOD, V75, P2375
[8]  
Golay J, 2000, BLOOD, V95, P3900
[9]   TARGETING, DOSIMETRY, AND RADIOIMMUNOTHERAPY OF B-CELL LYMPHOMAS WITH IODINE-131-LABELED LL2 MONOCLONAL-ANTIBODY [J].
GOLDENBERG, DM ;
HOROWITZ, JA ;
SHARKEY, RM ;
HALL, TC ;
MURTHY, S ;
GOLDENBERG, H ;
LEE, RE ;
STEIN, R ;
SIEGEL, JA ;
IZON, DO ;
BURGER, K ;
SWAYNE, LC ;
BELISLE, E ;
HANSEN, HJ ;
PINSKY, CM .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) :548-564
[10]  
Green JM, 2000, BLOOD, V96, p133A
12345